XML 26 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Conversion Of Redeemable Convertible Preferred Stock To Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Conversion Of Redeemable Convertible Preferred Stock To Common Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Class A
Class A
Common Stock
Class A
Common Stock
Conversion Of Class B Common Stock To Class A Common Stock
Class A
Common Stock
Conversion Of Redeemable Convertible Preferred Stock To Common Stock
Class B
Class B
Conversion Of Class B Common Stock To Class A Common Stock
Class B
Common Stock
Class B
Common Stock
Conversion Of Class B Common Stock To Class A Common Stock
Class B
Common Stock
Conversion Of Redeemable Convertible Preferred Stock To Common Stock
Beginning balance (in shares) at Dec. 31, 2023 73,021,449                            
Beginning balance at Dec. 31, 2023 $ 1,853,492                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares) (73,021,449)                            
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering $ (1,853,492)                            
Ending balance (in shares) at Jun. 30, 2024 0                            
Ending balance at Jun. 30, 2024 $ 0                            
Beginning balance (in shares) at Dec. 31, 2023               7,099,700         53,904,204    
Beginning balance at Dec. 31, 2023 (412,922)   $ 302,820   $ 814 $ (716,562)   $ 0         $ 6    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon exercise of stock options, net (in shares)               3,394,138         813,648    
Issuance of common stock upon exercise of stock options, net 24,932   24,932                        
Issuance of common stock upon settlement of restricted stock units, net (in shares)               8,162,928         661,497    
Issuance of common stock upon settlement of restricted stock units, net (202,852)   (202,853)         $ 1              
Conversion of stock (in shares)                 20,142,152 5,104,017       (20,142,152) 67,917,432
Conversion of stock   $ 1,853,494   $ 1,853,486         $ 2 $ 1   $ 0   $ (2) $ 7
Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and other offering costs (in shares)               18,576,527              
Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and other offering costs 576,268   576,266         $ 2              
Stock-based compensation expense 641,774   641,774                        
Vesting of early exercised stock options 124   124                        
Net income (loss) (585,165)         (585,165)                  
Change in other comprehensive income (loss) (1,818)       (1,818)                    
Ending balance (in shares) at Jun. 30, 2024               62,479,462         103,154,629    
Ending balance at Jun. 30, 2024 $ 1,893,835   3,196,549   (1,004) (1,301,727)   $ 6         $ 11    
Ending balance (in shares) at Jun. 30, 2024 0                            
Ending balance at Jun. 30, 2024 $ 0                            
Beginning balance (in shares) at Mar. 31, 2024               44,286,735         119,059,756    
Beginning balance at Mar. 31, 2024 1,838,300   3,130,384   (472) (1,291,628)   $ 4         $ 12    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon exercise of stock options, net (in shares)               252,962         7,700    
Issuance of common stock upon exercise of stock options, net 1,843   1,843                        
Issuance of common stock upon settlement of restricted stock units, net (in shares)               1,989,556         37,382    
Conversion of stock (in shares)                 15,950,209         (15,950,209)  
Conversion of stock   $ 2   $ 1         $ 2     0   $ (2) $ 1
Stock-based compensation expense 64,266   64,266                        
Vesting of early exercised stock options 55   55                        
Net income (loss) (10,099)         (10,099)                  
Change in other comprehensive income (loss) (532)       (532)                    
Ending balance (in shares) at Jun. 30, 2024               62,479,462         103,154,629    
Ending balance at Jun. 30, 2024 $ 1,893,835   3,196,549   (1,004) (1,301,727)   $ 6         $ 11    
Beginning balance (in shares) at Dec. 31, 2024 0                            
Beginning balance at Dec. 31, 2024 $ 0                            
Ending balance (in shares) at Jun. 30, 2025 0                            
Ending balance at Jun. 30, 2025 $ 0                            
Beginning balance (in shares) at Dec. 31, 2024             125,001,880 125,001,880     55,314,099   55,314,099    
Beginning balance at Dec. 31, 2024 $ 2,130,749   3,331,546   24 (1,200,838)   $ 12         $ 5    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon exercise of stock options, net (in shares) 2,819,924             1,363,474         1,456,450    
Issuance of common stock upon exercise of stock options, net $ 14,487   14,487                        
Issuance of common stock upon settlement of restricted stock units, net (in shares)               3,904,250         34,502    
Issuance of common stock upon settlement of restricted stock units, net (51,898)   (51,899)         $ 1              
Conversion of stock (in shares)                 1,692,925         (1,692,925)  
Conversion of stock                 $ 0     $ 0   $ 0  
Stock-based compensation expense 174,484   174,484                        
Net income (loss) 115,455         115,455                  
Change in other comprehensive income (loss) 3,703       3,703                    
Ending balance (in shares) at Jun. 30, 2025             131,962,529 131,962,529     55,112,126   55,112,126    
Ending balance at Jun. 30, 2025 $ 2,386,980   3,468,618   3,727 (1,085,383)   $ 13         $ 5    
Ending balance (in shares) at Jun. 30, 2025 0                            
Ending balance at Jun. 30, 2025 $ 0                            
Beginning balance (in shares) at Mar. 31, 2025               129,145,465         55,121,821    
Beginning balance at Mar. 31, 2025 2,217,121   3,390,469   1,314 (1,174,680)   $ 13         $ 5    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon exercise of stock options, net (in shares)               358,393         629,769    
Issuance of common stock upon exercise of stock options, net 4,303   4,303                        
Issuance of common stock upon settlement of restricted stock units, net (in shares)               1,801,956         17,251    
Issuance of common stock upon settlement of restricted stock units, net (15,224)   (15,224)         $ 0              
Conversion of stock (in shares)                 656,715         (656,715)  
Stock-based compensation expense 89,070   89,070                        
Net income (loss) 89,297         89,297                  
Change in other comprehensive income (loss) 2,413       2,413                    
Ending balance (in shares) at Jun. 30, 2025             131,962,529 131,962,529     55,112,126   55,112,126    
Ending balance at Jun. 30, 2025 $ 2,386,980   $ 3,468,618   $ 3,727 $ (1,085,383)   $ 13         $ 5